Skip to main content
. 2023 May 5;2023(5):CD006103. doi: 10.1002/14651858.CD006103.pub8

NCT02991781.

Study name Combined bio‐ and neuro‐ feedback vs. varenicline use for smoking cessation
Methods RCT
Participants Unemployed adults < 35 who smoke (subgroup of a larger trial population)
Interventions
  • Biofeedback and neurofeedback training

  • Varenicline use for smoking cessation

  • Sham neurofeedback

  • Passive control

Outcomes Abstinence at 2 years
Starting date January 2017
Contact information Principal Investigator: Panos Bamidis, Ass. Prof, Medical School, Aristotle University of Thessaloniki
Notes